MIP Diagnostics Overview

  • Founded
  • 2015
Founded
  • Status
  • Private
  • Employees
  • 19
Employees
  • Latest Deal Type
  • Later Stage VC
  • Latest Deal Amount
  • $6.38M
Latest Deal Amount
  • Investors
  • 7

MIP Diagnostics General Information

Description

Developer of molecular imprinted polymers (MIPS) and nanoMIPs/plastic antibodies technology designed to circumvent the drawbacks of traditional MIP manufacturing methods. The company's polymers and antibodies typically contain a single binding site for their target and can be fused to solid substrates, such as sensor surfaces, thus providing hospitals with ideal reagents for a wide range of applications including point-of-care diagnostics and in field-based testing.

Contact Information

Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Healthcare Technology Systems
Primary Office
  • The Exchange Building
  • Colworth Park, Sharnbrook
  • Bedford MK44 1LQ
  • England, United Kingdom
+44 01234 000000

MIP Diagnostics Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

MIP Diagnostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC 01-Jul-2020 $6.38M 00.00 0000 Completed Generating Revenue
5. Early Stage VC (Series A) 08-May-2018 00.000 00.00 00.000 Completed Generating Revenue
4. Early Stage VC 28-Jun-2017 00000 00.000 00.000 Completed Generating Revenue
3. Early Stage VC 21-Oct-2016 00000 00000 00.000 Completed Startup
2. Early Stage VC 22-Dec-2015 $274K $274K 00.000 Completed Startup
1. Grant Completed Startup
To view MIP Diagnostics’s complete valuation and funding history, request access »

MIP Diagnostics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
C Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
C Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 00,000 00.000000 0000.00 0000.00 00 0000.00 00.000
B Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
B Ordinary 0,000 00.000000 0000.00 0000.00 00 0000.00 0.000
A Ordinary 0,000 00.000000 000.00 000.00 00 000.00 0.000
A Ordinary 3,308 $0.012513 $68.82 $68.82 1x $68.82 5.58%
A Ordinary 3,000 $0.012513 $62.56 $62.56 1x $62.56 5.06%
To view MIP Diagnostics’s complete cap table history, request access »

MIP Diagnostics Executive Team (6)

Name Title Board Seat Contact Info
Stephane Argivier Chief Executive Officer and Board Member
Alan Thomson Chief Scientific Officer
Antonio Guerreiro Ph.D Director, Technology & Co-Founder
Lowri Cope Chief Commercial Officer
Sergey Piletsky Ph.D Co-Founder
You’re viewing 5 of 6 executive team members. Get the full list »

MIP Diagnostics Board Members (7)

Name Representing Role Since
James Syrotiuk Self Board Member 000 0000
Jim Reid MIP Diagnostics Chairman 000 0000
Mark Payton Ph.D Self Board Member 000 0000
Stephane Argivier MIP Diagnostics Chief Executive Officer and Board Member 000 0000
William Brooks Self Board Member 000 0000
You’re viewing 5 of 7 board members. Get the full list »

MIP Diagnostics Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

MIP Diagnostics Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
BGF Growth/Expansion Minority 000 0000 000000 0
Downing Ventures Venture Capital Minority 000 0000 000000 0
Andrew Fisher Angel (individual) Minority 000 0000 000000 0
Calculus Capital PE/Buyout Minority 000 0000 000000 0
David Evans Angel (individual) Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »